2INVE

Lyxor Ibex 35 Doble Inverso Diario UCITS ETF

ETFs & Funds · EUR · BME

2INVEETF

Price

€0.324

+1.06%

Cap

Earnings

30d Trend

-6.9%

2INVE
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

43% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level70
Momentum16
Technical37
Fund Quality46
Cost Efficiency60

Raw weighted: 40×Macro 0.99 (1%)=40

RISK

70/100
90d Volatility
43.4%High
ATR %
3.1%High daily moves
Max Drawdown (1Y)
-48.5%Volatile

MOMENTUM

16/100
12-1M Momentum
-37.8%Strong downtrend
6-1M Momentum
-17.0%Negative
1M Return
-7.9%Recent pullback

TECHNICAL

37/100
RSI (14)
37.8Neutral
Price vs SMA200
-21.9%Bearish trend
MACD
0.00Bearish momentum
Bollinger Band
0%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.211Noisy/choppy

FUND QUALITY

46/100
Replication
SyntheticUses swaps (counterparty risk)
Domicile
FranceCheck tax treaty

COST EFFICIENCY

60/100
Expense Ratio
0.40%Moderate
Fund Size (AUM)
$175MSmall

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months49
3-12 months21
1-5+ years44

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Lyxor Ibex 35 Doble Inverso Diario UCITS ETF at 40/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is cost efficiency at 60/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-7.9%

3 MONTHS

-5.2%

12 MONTHS

-45.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Cost Efficiency (60) and Fund Quality (46) are the primary strengths. I note that momentum is the weakest area at 16/100 — this warrants monitoring. Historical volatility is elevated at 43%. I classify this as a speculative position — elevated volatility at 43% and asymmetric payoff potential define the opportunity.

speculativeScore: 40/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.